Actively Recruiting
Exploring ENLIGHT Algorithm to Guide Treatment Options for Advanced Metastatic Breast Cancer
Led by National Cancer Institute (NCI) · Updated on 2026-08-21
175
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether a computational algorithm called ENLIGHT can help identify better treatment options for people with aggressive forms of breast cancer, specifically triple-negative breast cancer and endocrine therapy-resistant metastatic breast cancer. These cancers often have limited effective treatments and poor survival rates, so the study explores using advanced RNA sequencing data to guide therapy choices beyond current DNA-based methods. The study aims to assess the feasibility and effectiveness of ENLIGHT in matching patients to off-label therapies. Participants will have tumor tissue samples tested using ENLIGHT and another genomic method TruSight Oncology 500. Based on the algorithms recommendations, participants are assigned to one of three groups those with no recommended drug option will continue standard care those recommended drugs already approved but not yet received will have results sent to their local doctors and those recommended drugs approved for other uses will receive treatment at the NIH with ongoing management. Treatments continue as long as beneficial, with follow-up visits for two years post-treatment. During the study, participants will undergo screening, biopsies if needed, and tissue testing. Those treated at NIH will provide blood samples and may have optional repeat biopsies during treatment. Researchers will monitor treatment responses, side effects, and duration of benefit, with health check-ins every three months for two years for those not treated at NIH. The primary outcomes include feasibility of the algorithm and objective response rate, with ongoing assessment of therapy matches, clinical benefits, and safety over the study period.
CONDITIONS
Brief Title
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Research Team
A
Ann C McCoy, R.N.
S
Stanley Lipkowitz, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here